On Episode 74 of Entrepreneur Rx, Dr. John Shufeldt sat down with Dr. Stanley Lewis, an internal medicine physician, serial entrepreneur, and philanthropist. Stanley’s most recent endeavor is being the founder and CEO of A28 Therapeutics.
Stanley has a diverse background, starting with his medical training at the University of Texas McGovern School of Medicine and his work in patient care, education, and clinical research. He then transitioned to drug development and entrepreneurship, founding companies such as Eselle Health and A28 Therapeutics.
During their discussion, Staley candidly shares the driving force behind his pursuit of drug development, underscored by the pressing need for improved treatment options free from the toxic side effects of treatments for diseases like HIV and cancer. With passion, he unveils the distinctive approach of his current company, A28 Therapeutics, which pioneers a targeted lytic peptide for combating cancer, with a particular emphasis on liver metastases.
Lastly, Stanley eloquently underscores the significance of diversity within medicine and the biotech industry. He highlights the profound impact it can have on health outcomes and the importance of representing diverse voices and perspectives. As a seasoned entrepreneur, he imparts valuable advice to those aspiring to make their mark, emphasizing the significance of knowing their "why," exercising patience and persistence and fostering a collaborative spirit in their endeavors.
